Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Better living through conifer removal: A demographic analysis of sage-grouse vital rates.

Severson JP, Hagen CA, Tack JD, Maestas JD, Naugle DE, Forbes JT, Reese KP.

PLoS One. 2017 Mar 23;12(3):e0174347. doi: 10.1371/journal.pone.0174347. eCollection 2017.

2.

Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells.

Miller TW, Forbes JT, Shah C, Wyatt SK, Manning HC, Olivares MG, Sanchez V, Dugger TC, de Matos Granja N, Narasanna A, Cook RS, Kennedy JP, Lindsley CW, Arteaga CL.

Clin Cancer Res. 2009 Dec 1;15(23):7266-76. doi: 10.1158/1078-0432.CCR-09-1665. Epub 2009 Nov 24.

3.

Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics.

Reyzer ML, Caldwell RL, Dugger TC, Forbes JT, Ritter CA, Guix M, Arteaga CL, Caprioli RM.

Cancer Res. 2004 Dec 15;64(24):9093-100.

4.

Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors.

Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, Moody SE, Chodosh LA, Arteaga CL.

Cancer Res. 2004 Dec 15;64(24):9002-11.

5.

Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowski MX, Forbes JT, Arteaga CL.

Cancer Res. 2000 Oct 15;60(20):5887-94.

6.

Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.

Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9609-14.

8.

Evidence for a positive role of transforming growth factor-beta in human breast cancer cell tumorigenesis.

Arteaga CL, Dugger TC, Winnier AR, Forbes JT.

J Cell Biochem Suppl. 1993;17G:187-93.

PMID:
8007696
9.

Acute endotoxin-induced lymphocyte subset sequestration in sheep lungs.

Duke SS, Guerry-Force ML, Forbes JT, Stewart SJ, King G, Wickersham N, Brigham KL, Meyrick B.

Lab Invest. 1990 Mar;62(3):355-62.

PMID:
2179624
10.

Human recombinant interleukin 2-activated sheep lymphocytes lyse sheep pulmonary microvascular endothelial cells.

Duke SS, King LS, Jones MR, Newman JH, Brigham KL, Forbes JT.

Cell Immunol. 1989 Aug;122(1):188-99.

PMID:
2787699
11.

Bacterial toxins affect early events of T lymphocyte activation.

Stewart SJ, Prpic V, Johns JA, Powers FS, Graber SE, Forbes JT, Exton JH.

J Clin Invest. 1989 Jan;83(1):234-42.

12.
13.

Phase I study of MVE-2 evaluating toxicity and biologic response modification capability.

Hainsworth JD, Forbes JT, Grosh WW, Greco FA.

Cancer Immunol Immunother. 1986;22(1):68-71.

PMID:
2423241
14.

Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice.

Fraker LD, Halter SA, Forbes JT.

Cancer Res. 1984 Dec;44(12 Pt 1):5757-63.

15.

Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.

Johnson DH, Marangos PJ, Forbes JT, Hainsworth JD, Van Welch R, Hande KR, Greco FA.

Cancer Res. 1984 Nov;44(11):5409-14.

16.

Pleiotropic activities of human interferons are mediated by multiple response pathways.

Forti RL, Mitchell WM, Hubbard WC, Workman RJ, Forbes JT.

Proc Natl Acad Sci U S A. 1984 Jan;81(1):170-4.

17.

Natural killer cell activity during murine Schistosomiasis mansoni.

Abe T, Forbes JT, Colley DG.

J Parasitol. 1983 Dec;69(6):1001-5.

PMID:
6674448
18.

A functional cyclooxygenase enzyme is not required for mediation of the pleiotropic effects of human alpha or beta interferon.

Forti RL, Mitchell WM, Workman RJ, Forbes JT, Hubbard WC.

Prostaglandins. 1983 Sep;26(3):409-20.

PMID:
6419287
19.

Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer.

Oldham RK, Gail MH, Baker MA, Forbes JT, Heineman W, Hersh E, Holmes EC, Ritts RE, Wright PW.

Cancer Immunol Immunother. 1982;13(3):164-73.

PMID:
6762247
20.

Mannose 6-, fructose 1-, and fructose 6-phosphates inhibit human natural cell-mediated cytotoxicity.

Forbes JT, Bretthauer RK, Oeltmann TN.

Proc Natl Acad Sci U S A. 1981 Sep;78(9):5797-801.

21.
22.
23.

The unrecognized extragonadal germ cell cancer syndrome.

Richardson RL, Schoumacher RA, Fer MF, Hande KR, Forbes JT, Oldham RK, Greco FA.

Ann Intern Med. 1981 Feb;94(2):181-6.

PMID:
6162409
24.

Human granulocyte-specific nuclear antigen(s). II. Detection of antigens in human proliferative syndromes.

Briggs RC, Forbes JT, Hnilica LS, Montiel MM, Thor DE.

J Immunol. 1980 Jan;124(1):243-9.

PMID:
6153097
25.

Immunologic aspects of small cell carcinoma.

Forbes JT, Greco FA, Oldham RK.

Semin Oncol. 1978 Sep;5(3):263-71. Review. No abstract available.

PMID:
80823
26.

Soluble tumor antigen-induced lymphocyte proliferation: effects of serum from normal and tumor-bearing mice.

Calderwood MB, Forbes JT, Smith RT.

Int J Cancer. 1977 Sep 15;20(3):400-7.

PMID:
903190
27.

Alcohol toxicity in cell culture.

Freund G, Forbes JT.

Life Sci. 1976 Oct 1;19(7):1067-72. No abstract available.

PMID:
994711
29.

Specific antigen stimulated lymphocyte proliferation in osteosarcoma.

Gainor BJ, Forbes JT, Enneking WF, Smith RT.

Cancer. 1976 Feb;37(2):743-50.

PMID:
1062227
30.

T mitogens trigger LPS responsiveness in mouse thymus cells.

Forbes JT, Nakao Y, Smith RT.

J Immunol. 1975 Mar;114(3):1004-7.

PMID:
122988
31.

The stimulation and inhibition of nonimmune lymphocyte-mediated cytotoxicity in vitro.

Shivers BR, Forbes JT, Cruse JM, Gillespie GY, Hester RB.

J Reticuloendothel Soc. 1972 Sep;12(3):257-82. No abstract available.

PMID:
5074439
32.

Dissection of the immunosuppressive effect of the Fc region of tumor-enhancing IgG.

Cruse JM, Forbes JT, Gillespie GY, Lewis GK, Scales RW, Shivers BR, Fields JF, Hester RB, Watson ES, Whitten HD.

Z Immunitatsforsch Exp Klin Immunol. 1972 Jan;143(1):43-58. No abstract available.

PMID:
4282906
33.

A synergistic immunosuppressive effect of endotoxin and PHA-M on immunologic enhancement in mice.

Cruse JM, Forbes JT, Shivers BR, Gillespie GY, Lewis GK, Scales RW, Fields JF, Hester RB, Watson ES, Whitten HD.

Z Immunitatsforsch Exp Klin Immunol. 1972 Jan;143(1):31-42. No abstract available.

PMID:
4282905
34.

Immunologic enhancement induced by antibody fragments.

Cruse JM, Forbes JT, Gillespie GY, Lewis GK.

Z Immunitatsforsch Allerg Klin Immunol. 1970;140(3):259-67. No abstract available.

PMID:
4251393

Supplemental Content

Loading ...
Support Center